ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced this morning that it has executed a Material Transfer Agreement (MTA) with Archimedes Development Limited. This collaboration enables the companies to identify possible synergies between their technology platforms.

“Multiple studies in different model systems have shown that Homspera can protect experimental animals and enhance their immune responses to vaccine-delivered antigens, DNA-encoded viral proteins or tumor antigens, as well as provide protection in our anthrax and influenza therapeutic studies,” stated Hal Siegel, Ph.D., ImmuneRegen’s Vice President and Chief Scientific Officer.

He continued, “In addition to these findings in animals where Homspera has been administered intranasally as a liquid, inhaled or injected under the skin, we have shown in laboratory studies that Homspera can stimulate blood-forming stem cells to produce more white blood cell precursors, particularly those for granulocytes and macrophages, mature blood cells which play a significant role in

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

Wednesday August 26, 2009

PennyOmega.com Stock Report!

**************************************************************

Raser Technologies, Inc. (NYSE: RZ), an energy technology company, announced results from a recent test drive demonstrating over 50 miles of all-electric range by its electric Hummer H3E during a preliminary road test.

TIBCO Software Inc. (NASDAQ: TIBX), today announced the general availability of TIBCO Collaborative Information Manager(TM) version 7.2.1 — the first enterprise master data management (MDM) platform to provide out-of-the box functionality that offers customers powerful new tools to address their data integrity challenges using machine intelligence.

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration,